Anthony J. Busti

1.2k total citations
23 papers, 827 citations indexed

About

Anthony J. Busti is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Anthony J. Busti has authored 23 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Emergency Medicine and 10 papers in Virology. Recurrent topics in Anthony J. Busti's work include HIV/AIDS drug development and treatment (12 papers), HIV-related health complications and treatments (11 papers) and HIV Research and Treatment (10 papers). Anthony J. Busti is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV-related health complications and treatments (11 papers) and HIV Research and Treatment (10 papers). Anthony J. Busti collaborates with scholars based in United States and Italy. Anthony J. Busti's co-authors include Justin Shane Hooper, Salahuddin Kazi, Ronald G. Hall, David M. Margolis, Roger Bedimo, Byron Cryer, Jennifer E. Cole, Claudia Meek, Richard D. Leff and Roger Bedimo and has published in prestigious journals such as The American Journal of Medicine, AIDS and Drug Safety.

In The Last Decade

Anthony J. Busti

23 papers receiving 791 citations

Peers

Anthony J. Busti
William A. Briggs United States
Arnaud D. Kazé United States
S. Cox Australia
R. Vanholder Belgium
Heath R Jennings United States
Robert B. Dorman United States
William A. Briggs United States
Anthony J. Busti
Citations per year, relative to Anthony J. Busti Anthony J. Busti (= 1×) peers William A. Briggs

Countries citing papers authored by Anthony J. Busti

Since Specialization
Citations

This map shows the geographic impact of Anthony J. Busti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Busti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Busti more than expected).

Fields of papers citing papers by Anthony J. Busti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony J. Busti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Busti. The network helps show where Anthony J. Busti may publish in the future.

Co-authorship network of co-authors of Anthony J. Busti

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony J. Busti. A scholar is included among the top collaborators of Anthony J. Busti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony J. Busti. Anthony J. Busti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellone, Simonetta, et al.. (2010). Etiopathogenetic advances and management of holoprosencephaly: from bench to bedside.. PubMed. 52(4). 345–54. 5 indexed citations
2.
3.
Chow, Dominic C., Huichao Chen, Marshall J. Glesby, et al.. (2009). Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients. AIDS. 23(16). 2133–2141. 30 indexed citations
4.
Nguyen, Sean, et al.. (2008). Acute elevation of triglycerides after initiation of fosamprinavir/ritonavir in an HIV-negative patient with baseline hypertriglyceridemia. Journal of clinical lipidology. 2(5). 398–400. 1 indexed citations
5.
Álvarez, Carlos A., et al.. (2008). Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population. Journal of clinical lipidology. 2(6). 447–452. 1 indexed citations
6.
White, Elizabeth, et al.. (2008). A Multimodal, Evidence‐Based Approach to Achieve Lipid Targets in the Treatment of Antiretroviral‐Associated Dyslipidemia: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(7). 932–938. 7 indexed citations
7.
Nguyen, Sean, et al.. (2008). Safety and Efficacy of Simvastatin for the Treatment of Dyslipidemia in Human Immunodeficiency Virus‐Infected Patients Receiving Efavirenz‐Based Highly Active Antiretroviral Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(7). 913–919. 16 indexed citations
8.
Hall, Ronald G., et al.. (2008). Multicenter Evaluation of Vancomycin Dosing: Emphasis on Obesity. The American Journal of Medicine. 121(6). 515–518. 50 indexed citations
9.
Bedimo, Roger, et al.. (2008). The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients. American Journal of Infectious Diseases. 4(2). 147–151. 2 indexed citations
10.
Nguyen, Sean, et al.. (2008). Lipid‐Lowering Efficacy and Safety After Switching to Atazanavir‐Ritonavir‐Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(3). 323–330. 23 indexed citations
11.
Busti, Anthony J., Ronald G. Hall, Roger Bedimo, et al.. (2008). Effects of Atazanavir/Ritonavir or Fosamprenavir/Ritonavir on the Pharmacokinetics of Rosuvastatin. Journal of Cardiovascular Pharmacology. 51(6). 605–610. 81 indexed citations
12.
Bedimo, Roger, Anthony J. Busti, Ronald G. Hall, et al.. (2008). 100: Effects of Atazanavir/Ritonavir or Fosamprenavir/Ritonavir on the Pharmacokinetics of Rosuvastatin. Journal of clinical lipidology. 2(3). 202–202. 1 indexed citations
14.
Hooper, Justin Shane, et al.. (2007). Evidence-based treatment recommendations for uremic bleeding. Nature Clinical Practice Nephrology. 3(3). 138–153. 140 indexed citations
15.
Motsko, Stephen P., Karen L. Rascati, Anthony J. Busti, et al.. (2006). Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk. Drug Safety. 29(7). 621–632. 80 indexed citations
16.
Cole, Jennifer E., Anthony J. Busti, & Salahuddin Kazi. (2006). The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran’s Affairs patients receiving tumor necrosis factor alpha antagonists. Rheumatology International. 27(4). 369–373. 43 indexed citations
17.
Busti, Anthony J., et al.. (2005). Effects of Perioperative Antiinflammatory and Immunomodulating Therapy on Surgical Wound Healing. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(11). 1566–1591. 152 indexed citations
18.
Busti, Anthony J. & Henry I. Bussey. (2004). The Role of Oral Direct Thrombin Inhibitors in the Treatment of Venous Thromboembolism. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(10P2). 184S–189S. 2 indexed citations
19.
Busti, Anthony J., et al.. (2004). Tegaserod‐Induced Myocardial Infarction: Case Report and Hypothesis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(4). 526–531. 57 indexed citations
20.
Busti, Anthony J., Ronald G. Hall, & David M. Margolis. (2004). Atazanavir for the Treatment of Human Immunodeficiency Virus Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(12). 1732–1747. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026